Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids

This study has been completed.

Study NCT00691873 Information provided by University of Mississippi Medical Center

First Received: June 3, 2008 Last Updated: June 5, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	October 2007
Primary Completion Date:	May 2007 (Final data collection date for primary outcome measure)